Search result for US trial
NOVAVAX COVID-19 VACCINE WAS 90 PERCENT EFFECTIVE IN PHASE 3 US TRIAL
Highlights
• As per phase 3 trial which was conducted the US and Mexico, the vaccine had an overall efficacy of 90.4% in a group of 29,960 participants across 119 sites in the country
According to a report released by US-based company Novavax on the basis of ongoing phase...
ASTRAZENECA HOPEFUL ABOUT RESUMPTION OF U.S. VACCINE TRIALS
Highlights
• Reports state that AstraZeneca is hopeful that the global approval will be determined by results in tests conducted outside the U.S.
• Human clinical trials in the U.S. were halted by the FDA in early September after a volunteer came down with unex...